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ABSTRACT 
 
The intercalation of L-phenylalanate (LP) into the interlayer gallery of zinc layered hydroxide 
(ZLH) has been successfully executed using a simple direct reaction method. The synthesised 
intercalation compound, zinc layered hydroxide-L-phenylalanate (ZLH-LP), was 
characterised using PXRD, FTIR, CHNS, ICP-OES, TGA/DTG, FESEM and TEM. The 
PXRD patterns of the intercalation compound demonstrate an intense and symmetrical peak, 
indicating a well-ordered crystalline layered structure. The appearance of an intercalation 
peak at a low angle of 2θ with a basal spacing of 16.3 Å, signifies the successful intercalation 
of the L-phenylalanate anion into the interlayer gallery of the host. The intercalation is also 
validated by FTIR spectroscopy and CHNS elemental analysis. Thermogravimetric analysis 
confirms that the ZLH-LP intercalation compound has higher thermal stability than the 
pristine L-phenylalanine. The observed percentage of L-phenylalanate accumulated release 
varies in each release media, with 84.5%, 79.8%, 63.8% and 61.8% release in phosphate 
buffer saline (PBS) solution at pH 4.8, deionised water, PBS solution at pH 7.4 and NaCl 
solution, respectively. The release behaviour of LP from its intercalation compounds in 
deionised water and PBS solution at pH 4.8 follows pseudo second order, whereas in NaCl 
solution and PBS solution at pH 7.4, it follows the parabolic diffusion model. This study 
shows that the synthesised ZLH-LP intercalation compound can be used for the formation of 
a new generation of materials for targeted drug release with controlled release properties. 
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